Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Theralase Technologies Inc (TLT.VN)

Theralase Technologies Inc (TLT.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Theralase Technologies Inc 41 Hollinger Road Toronto ON M4B 3G4 CAN

https://www.theralase.com P: 416-699-5273 F: 416-699-5250

Description:

Theralase Technologies Inc is a clinical-stage pharmaceutical company. It is dedicated to the research and development of light-activated Photo Dynamic Compounds, their associated drug formulations, and technology platforms intended to safely and effectively; treat various cancers, bacteria, and viruses. The Cool Laser Technology division designs, develops, manufactures, and markets proprietary super-pulsed laser technology indicated and cleared by Health Canada and the FDA for the healing of chronic knee pain and when used off-label for healing numerous nerve, muscle, and joint conditions. The ACT division conducts preclinical and clinical research and development for PDCs, in the treatment of cancer, with assistance from the CLT division to develop medical lasers to activate them.

Key Statistics

Overview:

Market Capitalization, $K 37,620
Shares Outstanding, K 235,128
Annual Sales, $ 1,070 K
Annual Net Income, $ -4,571 K
Last Quarter Sales, $ 364 K
Last Quarter Net Income, $ -991 K
60-Month Beta 1.32
% of Institutional Shareholders 0.20%

Growth:

1-Year Return -38.00%
3-Year Return -30.43%
5-Year Return -65.59%
5-Year Revenue Growth -9.20%

Per-Share Information:

Latest Earnings Date 06/04/24
Earnings Per Share ttm -0.02
EPS Growth vs. Prev Year -18.52%
Dividend Payout Ratio 0.00%

TLT.VN Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -182.91%
Return-on-Assets % -122.91%
Profit Margin % -427.06%
Debt/Equity 0.15
Price/Sales 32.88
Price/Book 19.74
Book Value/Share 0.01
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar